BREXOGEN
韩国
展位号: S363
行业类别
公司简介
At Brexogen, we are developing biomacromolecule cargo-controlled exosome as a cell-free regenerative medicine. By using induced pluripotent stem cells derived mesenchymal stem cells and stem cell stimulation technologies, we control the biomacromolecule cargo potential and composition inside exosome.
English
Español
Français
Português
Русский
简体中文